Ireland, UK working on new fee proposals for medtech industry
This article was originally published in Clinica
Executive Summary
Ireland and the UK are the latest EU member states to announce plans for a new fee-based system for the regulation of medical devices. It seems likely they will join the many other EU member states have systems to recoup all, or the majority, of their costs associated with the regulation of medical devices.
You may also be interested in...
IVD UK Spring Meeting: The Costly But Necessary Route To IVDR Compliance
Second of two articles covering discussion at the spring 2017 meeting of the British In Vitro Diagnostics Association: Not all will survive unscathed as the EU IVD Regulation becomes an operational reality.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.